• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性肾脏病中的动脉僵硬度:病因与后果。

Arterial stiffness in chronic kidney disease: causes and consequences.

机构信息

Department of Cardiology, Queen Elizabeth Hospital Birmingham and University of Birmingham, Birmingham, UK.

出版信息

Heart. 2010 Jun;96(11):817-23. doi: 10.1136/hrt.2009.184879. Epub 2010 Apr 20.

DOI:10.1136/hrt.2009.184879
PMID:20406771
Abstract

Chronic kidney disease is associated with elevated cardiovascular risk, and heart failure and arrhythmias are the biggest causes of cardiovascular death in this population. Increased arterial stiffness is a hallmark of chronic kidney disease and is associated with adverse alterations in cardiac structure and function that may predispose to an increased risk of cardiovascular death. These changes are already apparent in early kidney disease, which is highly prevalent in the developed world. The mechanisms underlying increased arterial stiffness in chronic kidney disease are undoubtedly complex, but an understanding is paramount to enable the development of novel therapeutic strategies to prevent or reverse this pathophysiology and therefore reduce the cardiovascular disease burden in this high-risk cohort.

摘要

慢性肾脏病与心血管风险升高有关,心力衰竭和心律失常是该人群心血管死亡的最大原因。动脉僵硬度增加是慢性肾脏病的一个标志,与心脏结构和功能的不良改变有关,这些改变可能增加心血管死亡的风险。这些变化在早期肾脏病中已经很明显,而早期肾脏病在发达国家非常普遍。慢性肾脏病中动脉僵硬度增加的机制无疑是复杂的,但了解这些机制对于开发新的治疗策略以预防或逆转这种病理生理学,从而降低高危人群的心血管疾病负担至关重要。

相似文献

1
Arterial stiffness in chronic kidney disease: causes and consequences.慢性肾脏病中的动脉僵硬度:病因与后果。
Heart. 2010 Jun;96(11):817-23. doi: 10.1136/hrt.2009.184879. Epub 2010 Apr 20.
2
Republished paper: Arterial stiffness in chronic kidney disease: causes and consequences.再刊论文:慢性肾脏病中的动脉僵硬度:病因与后果。
Postgrad Med J. 2010 Sep;86(1019):560-6. doi: 10.1136/pgmj.2009.184879rep.
3
Causes and consequences of increased arterial stiffness in chronic kidney disease patients.慢性肾病患者动脉僵硬度增加的原因及后果
Kidney Blood Press Res. 2007;30(2):97-107. doi: 10.1159/000100905. Epub 2007 Mar 19.
4
Is lowering phosphate exposure the key to preventing arterial stiffening with age?降低磷酸盐暴露是预防动脉随年龄增长而硬化的关键吗?
Heart. 2009 Nov;95(21):1770-2. doi: 10.1136/hrt.2008.162594. Epub 2009 Mar 24.
5
Special characteristics of atherosclerosis in chronic renal failure.慢性肾衰竭中动脉粥样硬化的特殊特征。
Clin Nephrol. 2003 Jul;60 Suppl 1:S13-21.
6
[Cardiovascular system in patients in different stages of chronic kidney disease].[慢性肾脏病不同阶段患者的心血管系统]
Pol Merkur Lekarski. 2006 Aug;21(122):125-9; discussion 130-1.
7
[Cardiovascular risk factors in chronic renal failure].[慢性肾衰竭中的心血管危险因素]
Nefrologia. 2002;22 Suppl 1:59-67.
8
Stepwise increase in arterial stiffness corresponding with the stages of chronic kidney disease.动脉僵硬度随慢性肾脏病各阶段逐步增加。
Am J Kidney Dis. 2005 Mar;45(3):494-501. doi: 10.1053/j.ajkd.2004.11.011.
9
Regional arterial stiffness in patients with type 2 diabetes and chronic kidney disease.2型糖尿病合并慢性肾脏病患者的局部动脉僵硬度
J Am Soc Nephrol. 2006 Aug;17(8):2245-52. doi: 10.1681/ASN.2005101038. Epub 2006 Jul 12.
10
Are biomarkers useful for assessing cardiovascular risk in patients with chronic kidney disease?生物标志物对评估慢性肾脏病患者的心血管风险有用吗?
Curr Opin Nephrol Hypertens. 2007 Nov;16(6):506-11. doi: 10.1097/MNH.0b013e3282f0b331.

引用本文的文献

1
Impaired vascular function in patients with chronic kidney disease who have elevated symmetric dimethylarginine but not asymmetric dimethylarginine.慢性肾病患者中血管功能受损,这些患者的对称二甲基精氨酸水平升高,但不对称二甲基精氨酸水平未升高。
Am J Physiol Renal Physiol. 2025 Sep 1;329(3):F391-F398. doi: 10.1152/ajprenal.00158.2025. Epub 2025 Aug 14.
2
Exploring the Interplay Between Kidney Dysfunction and Cardiovascular Disease.探索肾功能不全与心血管疾病之间的相互作用。
Med Sci (Basel). 2025 Jun 18;13(2):80. doi: 10.3390/medsci13020080.
3
Benefits of aldosterone receptor antagonism in chronic kidney disease: the BARACK-D RCT.
醛固酮受体拮抗剂在慢性肾脏病中的益处:BARACK-D随机对照试验
Health Technol Assess. 2025 Mar;29(5):1-130. doi: 10.3310/PYFT6977.
4
The Dual Burden: Exploring Cardiovascular Complications in Chronic Kidney Disease.双重负担:探索慢性肾脏病中的心血管并发症。
Biomolecules. 2024 Oct 31;14(11):1393. doi: 10.3390/biom14111393.
5
Arterial Stiffness and Chronic Kidney Disease Prediction.动脉僵硬度与慢性肾脏病预测
Arq Bras Cardiol. 2024 Mar 4;120(12):e20230779. doi: 10.36660/abc.20230779. eCollection 2024.
6
Association Between Arterial Stiffness and Measures of Autonomic Dysfunction in People With Chronic Kidney Disease.慢性肾病患者动脉僵硬度与自主神经功能障碍指标之间的关联
Can J Kidney Health Dis. 2023 Nov 21;10:20543581231213798. doi: 10.1177/20543581231213798. eCollection 2023.
7
Dyslipidemia in Patients with Chronic Kidney Disease: An Updated Overview.慢性肾脏病患者的血脂异常:最新综述。
Diabetes Metab J. 2023 Sep;47(5):612-629. doi: 10.4093/dmj.2023.0067. Epub 2023 Jul 24.
8
Cardiovascular complications in chronic kidney disease: a review from the European Renal and Cardiovascular Medicine Working Group of the European Renal Association.慢性肾脏病的心血管并发症:来自欧洲肾脏病协会的欧洲肾脏和心血管医学工作组的综述。
Cardiovasc Res. 2023 Sep 5;119(11):2017-2032. doi: 10.1093/cvr/cvad083.
9
Hypertension in kidney transplant recipients.肾移植受者的高血压
World J Transplant. 2022 Aug 18;12(8):211-222. doi: 10.5500/wjt.v12.i8.211.
10
Association of Ratio of Apolipoprotein B to Apolipoprotein A1 With Survival in Peritoneal Dialysis.载脂蛋白B与载脂蛋白A1的比值与腹膜透析患者生存率的关系
Front Nutr. 2022 Mar 25;9:801979. doi: 10.3389/fnut.2022.801979. eCollection 2022.